Evidence map›Paper›PMID 34511168›Full record

Trial reportZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics2021

Clinical effect of alfacalcidol in children with Henoch-Schönlein purpura: a prospective randomized controlled trial.

Qiang Fu, Ming-Fang Shi, Ying Chen

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Interventions for preventing and treating kidney disease in IgA vasculitis.The Cochrane database of systematic reviews · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Qiang FuDepartment of Pediatrics, First People's Hospital of Yibin, Yibin, Sichuan 644000, China.
Ming-Fang ShiDepartment of Pediatrics, First People's Hospital of Yibin, Yibin, Sichuan 644000, China.
Ying ChenDepartment of Pediatrics, First People's Hospital of Yibin, Yibin, Sichuan 644000, China.
Second People’s Hospital of Yibin · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo study the effects of alfacalcidol on serum 25-(OH)D

methodsA total of 200 children with HSP were prospectively enrolled from June 2018 to June 2020. According to the random number table method, they were divided into an observation group and a control group (

resultsAfter treatment, the observation group showed a significantly higher serum 25-(OH)D

conclusionsAlfacalcidol can increase the serum 25-(OH)D

Indexed as

IgA VasculitisChildHumansHydroxycholecalciferolsInterleukin-6Prospective StudiesalfacalcidolHydroxycholecalciferolsInterleukin-6AlfacalcidolChildHenoch-Schönlein purpuraImmunityInflammatory factor

Identifiers

PMID34511168
PMCPMC8428916
OpenAlexW3200275181

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.